| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/21/2004 | EP1149079B1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same |
| 04/21/2004 | EP1121099B1 Pharmaceutical composition with gastric residence and controlled release |
| 04/21/2004 | EP1105370B1 Novel aryl sulphonamides and analogues |
| 04/21/2004 | EP1071701A4 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 04/21/2004 | EP1049699B1 Pyrazolotriazines as crf antagonists |
| 04/21/2004 | EP1049671B1 Azetidinecarboxamide derivatives for the treatment of cns disorders |
| 04/21/2004 | EP1018341B1 Antistress agents and functional foods |
| 04/21/2004 | EP0964860B1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
| 04/21/2004 | EP0939654B1 Use of no syntase inhibitors with scavengers of oxygen reactive forms for the treatment of ischemia |
| 04/21/2004 | EP0774962B1 Use of dha in the treatment of dyslexia |
| 04/21/2004 | EP0683781B1 Novel inhibitors of adenosine monophosphate deaminase |
| 04/21/2004 | CN1491281A Neurotonin and use thereof |
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1491223A 3-indoline derivatives useful in treatment of psychiatric and neurologic disorders |
| 04/21/2004 | CN1491222A Piperidinee derivatives as neurokinin/antagonists |
| 04/21/2004 | CN1491221A Thiophene substituted amine derivatives as GLYT-1 inhibitors |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1491125A Use of flumazenil to produce medicament for treatment of cocaine dependency |
| 04/21/2004 | CN1490311A Bafuluomaidi as alpha No. subacceptor for blocking sympathetic nerve |
| 04/21/2004 | CN1490024A Preparations of composition and fumigant for prosopalgia |
| 04/21/2004 | CN1490007A Quinoline coridalis B drops and preparation thereof |
| 04/21/2004 | CN1490006A Melazocine masticatory and its preparation |
| 04/21/2004 | CN1489995A Amitriptyline hydrochloride drops and preparation thereof |
| 04/21/2004 | CN1489994A Extracts of fat soluble benzyl ethene contents from curcuma longa and use in preparation |
| 04/21/2004 | CN1146568C Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same |
| 04/21/2004 | CN1146567C 奥氮平二水合物d Olanzapine dihydrate d |
| 04/21/2004 | CN1146566C 2-aryl-8-oxodihydropurine derivatives, process for producing same, medicinal conty, same, and intermediates thereof |
| 04/21/2004 | CN1146563C Piperidinylmethyloxazolidinone derivative |
| 04/21/2004 | CN1146562C Thtraphydrothiopy 2,3-diazanaphthylaone derivatives as PDE4 inhibitors |
| 04/21/2004 | CN1146559C Muscarinic antagonists |
| 04/21/2004 | CN1146556C 1,2-dihydroindene or indoline derivatives, preparation and use thereof |
| 04/21/2004 | CN1146553C Hydroxymatatairesinol in cancer prevention |
| 04/21/2004 | CN1146551C Substituted diazacycloheptane compound, medicine composition contg, same and the use thereof |
| 04/21/2004 | CN1146549C Sulphenylxazolamines as therapeutic active ingredients |
| 04/21/2004 | CN1146545C Benzoylpyridazines |
| 04/21/2004 | CN1146544C Pyrazoelcarboxylic acid derivatives, their preparation, pharmaceutical compositions containing |
| 04/21/2004 | CN1146543C Serine protease inhibitor |
| 04/21/2004 | CN1146540C Novel compound with analgesic effect and use thereof |
| 04/21/2004 | CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 04/21/2004 | CN1146441C Composition of containing lympha toxin beta receptor |
| 04/21/2004 | CN1146430C Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 04/21/2004 | CN1146426C Stable aspirin-containing preparations for external use |
| 04/21/2004 | CN1146422C 2-methyl-thieno-benzodiazepine formulation |
| 04/21/2004 | CN1146420C Use of [R-(2)-alpha-(methoxylimino)-alpha-(1-azabicyclo[2,2,2]octa-3- radicle)-acetonitrile in preparation of medicine for psychoses |
| 04/21/2004 | CN1146412C Use of re-intake inhibitor of noradrenalin in preparatino of medicine against antagonistic |
| 04/21/2004 | CN1146410C Controlled release formulation |
| 04/20/2004 | US6723893 Mice having a mutant SOD-1-encoding transgene |
| 04/20/2004 | US6723845 Anhydrous mirtazapine crystals and process for preparing the same |
| 04/20/2004 | US6723841 Corticotropin-releasing factor2 receptors |
| 04/20/2004 | US6723830 Short peptides which selectively modulate the activity of protein kinases |
| 04/20/2004 | US6723754 Controlling pain using transferase inhibitor |
| 04/20/2004 | US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent |
| 04/20/2004 | US6723744 Indole carboxylic acids as thyroid receptor ligands |
| 04/20/2004 | US6723741 Benzimidazoles and benzothiazoles and uses thereof |
| 04/20/2004 | US6723740 Administering therapeutic amount of human peroxisome proliferator activated receptor delta agonist to lower triglycerides |
| 04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
| 04/20/2004 | US6723735 Imidazo-pyridine derivatives as ligands for GABA receptors |
| 04/20/2004 | US6723733 Polymerase inhibitor |
| 04/20/2004 | US6723730 Capsaicin receptor ligands |
| 04/20/2004 | US6723725 Indole derivatives |
| 04/20/2004 | US6723724 Isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof |
| 04/20/2004 | US6723723 Heterocyclic derivatives as inhibitors of factor Xa |
| 04/20/2004 | US6723721 CRF receptor antagonists and methods relating thereto |
| 04/20/2004 | US6723718 Substituted α, β-anellated butyrolactones |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723525 Methods and compositions for screening modulators of lipid kinases |
| 04/20/2004 | US6723344 Useful as implantable devices and wound dressings as the matrix of the invention is designed to be used in conjunction with such devices to provide protracted and controlled release of growth factor, to promote wound healing |
| 04/20/2004 | US6723343 Pharmaceutical tramadol salts |
| 04/20/2004 | US6723332 Oxomidazopyridine-carboxamides |
| 04/20/2004 | US6723315 Method for treating amyotrophic lateral sclerosis |
| 04/20/2004 | CA2246485C Novel derivatives of indole and indazole, process for their preparation and pharmaceutical compositions containing them |
| 04/20/2004 | CA2130678C 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof |
| 04/20/2004 | CA2054822C Formulations and their use in the treatment of neurological diseases |
| 04/15/2004 | WO2004031191A1 Azabicyclic spiroether derivatives as receptor antagonists |
| 04/15/2004 | WO2004031190A1 Azabicyclic amine derivatives as nk-1 receptor antagonists |
| 04/15/2004 | WO2004031189A1 Pyridino and pyrimidino pyrazinones for treatment of anxiety and depression |
| 04/15/2004 | WO2004031186A1 Morpholine-bridged indazole derivatives |
| 04/15/2004 | WO2004031181A1 Sulfonamide derivatives as antipsychotic agents |
| 04/15/2004 | WO2004031180A1 Quinazolin-4-one derivatives |
| 04/15/2004 | WO2004031177A1 2-aminobenzimidazole derivative |
| 04/15/2004 | WO2004031174A1 Imidazol-1-ylmethyl pyridazine derivatives |
| 04/15/2004 | WO2004031171A1 Isoquinoline compounds and medicinal use thereof |
| 04/15/2004 | WO2004031165A1 Remedies |
| 04/15/2004 | WO2004031161A1 Neurologically-active compounds |
| 04/15/2004 | WO2004031159A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
| 04/15/2004 | WO2004031155A1 ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF BOTH ENANTIOMERS OF 10,11-DIHYDRO-10-HYDROXY-5H-DIBENZ [b,f]AZEPINE-5-CARBOXAMIDE AND NEW CRYSTAL FORMS THEREOF |
| 04/15/2004 | WO2004031154A1 Novel lactams and uses thereof |
| 04/15/2004 | WO2004031151A1 Compounds capable of activating cholinergic receptors |
| 04/15/2004 | WO2004031148A1 Piperazine and piperidine derivatives for treatment of neurological diseases |
| 04/15/2004 | WO2004031139A1 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 04/15/2004 | WO2004031138A1 Novel sulphones for inhibition of gamma secretase |
| 04/15/2004 | WO2004031123A1 Hydroxyphenylundecane derivatives, a process for their production and their use |
| 04/15/2004 | WO2004030689A1 Composition containing eosinophil cationic protein |
| 04/15/2004 | WO2004030688A1 Novel method of controlling apoptosis by controlling interaction between proteins and drug using the same |
| 04/15/2004 | WO2004030668A1 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004013100A3 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 04/15/2004 | WO2004011632A3 Oligodendrocyte production from multipotent neural stem cells |